Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial

The Lancet Psychiatry

Fecha de publicación: 8 April 2019


Autores: Prof Simon Gilbody, DPhil., Emily Peckham, PhD., Della Bailey, MSc., Catherine Arundel, MSc., Paul Heron, MRes., Suzanne Crosland, PGDip., et al.

Background: People with severe mental illnesses such as schizophrenia are three times more likely to smoke than the wider population, contributing to widening health inequalities. Smoking remains the largest modifiable risk factor for this health inequality, but people with severe mental illness have not historically engaged with smoking cessation services. We aimed to test the effectiveness of a combined behavioural and pharmacological smoking cessation intervention targeted specifically at people with severe mental illness.

Seguir leyendo

Enviar comentario